Smoking cessation

Thorax

Volumn 55, Issue SUPPL. 1, 2000, Pages

  Campbell, I A ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; NICOTINE; NICOTINE GUM;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; SMOKING; SMOKING CESSATION; SUSTAINED RELEASE FORMULATION; WEIGHT GAIN;

EID: 0033925652     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.suppl_1.s28     Document Type: Article

References (47)

1. 1 Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999;340:685-91.
2. 2 Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997;337:1195-202.
3. 3 Tonnesen P, Paoletti P, Gustavsson G, et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Eur Respir J 1999;13:238-46.
4. 4 Jorenby DE, Smith SS, Fiore MC, et al. Varying nicotine patch dose and type of smoking cessation counselling. JAMA 1995;274:1347-52.
5. 5 Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of the nicotine patch for smoking cessation. JAMA 1994;271:1940-7.
6. 6 Tonnesen P, Norregard J, Simonsen K, et al. A double-blind trial of a 16 hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991;325:311-5.
7. 7 Westman EC, Levin ED, Rose J E. The nicotine patch in smoking cessation - a randomised trial with telephone counselling. Arch Intern Med 1993;153:1917-23.
8. 8 Jarvis MJ, Raw M, Russell MH, et al. Randomised controlled trial of nicotine chewing gum. BMJ 1982;285:537-40.
9. 9 Silagy C, Mant D, Fowler G, et al. Meta-analysis of efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139-42.
10. 10 Schneider NG, Jarvik ME, Forsythe AB, et al. Nicotine gum in smoking cesssation: a placebo-controlled, double-blind trial. Addict Behav 1983; 8:253-61.
11. 11 Sutherland G, Stapleton JA, Russell MAH, et al. Randomised controlled trial of nicotine nasal spray in smoking cessation. Lancet 1992;340: 324-8.
12. 12 Scheinder NG, Olmstad R, Mody FV, et al. Efficiency of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction 1995;90:1671-82.
13. 13 Hjalmarson A, Franzom M, Westin A, et al. Effect of nicotine nasal spray on smoking cessation: a randomised, placebo-controlled, double-blind study. Arch Intern Med 1994;154:2567-72.
14. 14 Blondal T, Franzom M, Westin A. A double-blind, randomised trial of nicotine nasal spray as an aid in smoking cessation. Eur Respir J 1997; 10:1585-90.
15. 15 Tonnesen P, Norregaard J, Mikkelsen K, et al. A double-blind trial of nicotine inhaler for smoking cessation. JAMA 1993;269:1268-71.
16. 16 Hjalmarson A, Nilsson F, Sjostrom L, et al. The nicotine inhaler in smoking cessation. Arch Intern Med 1997;157:1721-8.
17. 17 Kornitzer M, Boutsen M, Dramaix M, et al. Combined use of nicotine patch and gum on smoking cessation: a placebo-controlled clinical trial. Prev Med 1995;24:41-7.
18. 18 Puska P, Korhonem HJ, Bartiainem E, et al. Combined use of nicotine patch and gum compared with gum alone in smoking cessation: a clinical trial in North Karela. Tobacco Control 1995;4:231-5.
19. 19 Blondal T, Ludvikstottir D, Gudmundsson L et al. Nicotine nasal spray with nicotine patch for smoking cessation: a randomised trial with six-year follow-up. BMJ 1999;318:285-9.
20. 20 Russell MAH, Wilson C, Taylor C, et al. The effect of general practitioners' advice against smoking. BMJ 1979;2:231-5.
21. 21 Jamrozik K, Vessey M, Fowler G, et al. Controlled trial of three different anti-smoking interventions in general practice. BMJ 1984;288:1499-503.
22. 22 Richmond RL, Austin A, Webster IW. Three year evaluation of a programme by general practitioners to help patients stop smoking. BMJ 1986;292:803-6.
23. 23 Slama K, Redman S, Perkins J, et al. The effectiveness of two smoking cessation programmes for use in general practice: a randomised clinical trial. BMJ 1990;300:1707-9.
24. 24 Hollis JF, Lichtenstein E, Bot TM, et al. Nurse assisted counselling for smokers in primary care. Ann Intern Med 1993;118:521-5.
25. 25 Russell MAH, Merriman R, Stapleton J, et al. Effect of nicotine chewing gum as an adjunct to general practitioners' advice against smoking. BMJ 1983;287:1782-5.
26. 26 Jamrozik K, Fowler G, Vessey M, et al. Placebo controlled trial of nicotine chewing gum in general practice. BMJ 1984;298:794-7.
27. 27 Campbell IA, Lyons E, Prescott RJ. Stopping smoking: do nicotine chewing gum and postal encouragement add to doctors' advice? Practitioner 1987;231:144-7.
28. 28 Marshall A, Raw M. Nicotine chewing gum in general practice: effect of follow-up appointments. BMJ 1985;290:1397-8.
29. 29 Richmond RL, Makinson RJ, Kehoe A, et al. One-year evaluation of three smoking cessation interventions administered by general practitioners. Addict Behav 1993;18:187-99.
30. 30 Lamb W, Sze PC, Sacks HS, et al. Meta-analysis of randomised controlled trials of nicotine chewing gum. Lancet 1987;ii:27-30.
31. 31 Imperial Cancer Research Fund General Practice Research Group. Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. BMJ 1993;306: 1304-8.
32. 32 Russell MAH, Stapleton JA, Feyerbrand C, et al. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ 1993;306:1308-12.
33. 33 Stapleton JA, Russell MAH, Feyerbrand C, et al. Dose effects and predictors of outcome in randomised trial of transdermal nicotine patches in general practice. Addiction 1995;90:31-42.
34. 34 Yudkin PL, Jones L, Lancaster T, et al. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomised double-blind placebo-controlled trial. Br J Gen Pract 1996;46:145-8.
35. 35 Stapleton JA, Low IN, Russell MAH. Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost effectiveness. Lancet 1999;354:210-5.
36. 36 British Thoracic Society. Smoking withdrawal in hospital patients: factors associated with outcome. Thorax 1984;39:651-6.
37. 37 British Thoracic Society. Smoking cessation in patients: two further studies. Thorax 1990;45:835-40.
38. 38 Campbell IA, Tjeder-Burton SM, Prescott RJ. Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum. Respir Med 1991;85:155-7.
39. 39 Campbell IA, Prescott RJ, Tjeder-Burton SM. Transdermal nicotine plus support in patients attending hospital with smoking related diseases: placebo-controlled study. Respir Med 1996;90:47-51.
40. 40 Wilcox RG, Hughes J, Rowland J. Verification of smoking history after infarction using urinary nicotine and cotinine measurements. BMJ 1979;2:1026-8.
41. 41 Burt A, Illingworth D, Shore TRD, et al. Stopping smoking after myocardial infarction. Lancet 1974;i:304-6.
42. 42 British Thoracic Society. Comparison of four methods of smoking withdawal in patients with smoking related diseases. BMJ 1983;286: 595-7.
43. 43 Prathiba BV, Tjeder-Burton S, Phillips C, et al. A smoking cessation counsellor: should every hospital have one? J R Soc Health 1998;118: 356-9.
44. 44 Humerfelt S, Eide GE, Kvale G, et al. Effectiveness of postal smoking cessation advice: a randomised controlled trial in young men with reduced FEV, and asbestos exposure. Eur Respir J 1998;11:284-90.
45. 45 Hjalmarson AIM. Effect of nicotine chewing gum in smoking cessation. A randomised, placebo-controlled, double-blind study. JAMA 1984; 252:283-8.
46. 46 Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335:1792-8.
47. 47 Ascher JA, Cole JO, Colin JN, et al. Bupropion: a review of its mechanism of anti-depressant activity. J Clin Psychiatry 1995;56:395-401.